BioNTech SE ADR buy zonthiii
Start price
18.11.20
/
50%
€76.21
Target price
18.11.21
€90.00
Performance (%)
274.75%
End price
20.08.21
€285.60
Summary
This prediction ended on 20.08.21 with a price of €285.60. With a performance of 274.75% the BUY prediction by zonthiii was a big success. zonthiii has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | -5.585% | -6.284% | 8.869% | 8.070% |
iShares Nasdaq 100 | -7.241% | -13.117% | 18.200% | 28.955% |
iShares Nikkei 225® | -8.933% | -10.904% | 2.614% | -1.478% |
iShares S&P 500 | -6.148% | -7.562% | 17.896% | 31.811% |
According to zonthiii what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
negative Cash Flow expected
Significant cyclical dependencies
Comments by zonthiii for this prediction
In the thread Biontech SE diskutieren
Kursziel geändert auf 95,0
Kursziel geändert auf 90,0
Stopped prediction by zonthiii for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€74.64
17.11.20
17.11.20
€70.00
17.11.21
17.11.21
2.10%
18.11.20
18.11.20
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
BioNTech SE ADR
Start price
Target price
Perf. (%)
€85.01
16.11.20
16.11.20
€85.00
16.11.21
16.11.21
-12.20%
17.11.20
17.11.20
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group